100 related articles for article (PubMed ID: 26514971)
41. [Vaccination against human papillomavirus for the prevention of cervical cancer].
Quint WG; ter Harmsel WA; van Doorn LJ
Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585
[TBL] [Abstract][Full Text] [Related]
42. Quantifying the Effects of Medical Examination and Possible Risk Factors against the Incidence of Cervical Cancer in a Low Human Papillomavirus Vaccination Coverage: An Ecological Study in Japan.
Yu Y; Matsuyama R; Tsunematsu M; Kakehashi M
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638269
[TBL] [Abstract][Full Text] [Related]
43. Cervical Cancer Prophylaxis-State-of-the-Art and Perspectives.
Poniewierza P; Panek G
Healthcare (Basel); 2022 Jul; 10(7):. PubMed ID: 35885852
[TBL] [Abstract][Full Text] [Related]
44. Cervical cancer, geographical inequalities, prevention and barriers in resource depleted countries.
Bogdanova A; Andrawos C; Constantinou C
Oncol Lett; 2022 Apr; 23(4):113. PubMed ID: 35251344
[TBL] [Abstract][Full Text] [Related]
45. It Is All about Probiotics to Control Cervical Cancer.
Ashique S; Faruk A; Ahmad FJ; Khan T; Mishra N
Probiotics Antimicrob Proteins; 2024 Jun; 16(3):979-992. PubMed ID: 37880560
[TBL] [Abstract][Full Text] [Related]
46. A Comprehensive View of the Cancer-Immunity Cycle (CIC) in HPV-Mediated Cervical Cancer and Prospects for Emerging Therapeutic Opportunities.
Avila JP; Carvalho BM; Coimbra EC
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831674
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for the development of cervical cancer: analysis of the evidence.
Luvián-Morales J; Gutiérrez-Enríquez SO; Granados-García V; Torres-Poveda K
Front Oncol; 2024; 14():1378549. PubMed ID: 38846977
[TBL] [Abstract][Full Text] [Related]
48. Reflections on the life and career of Professor Dame Valerie Beral AC DBE FRS FRCOG FMedSci (1943-2022).
Canfell K; Liu B; Banks E
Med J Aust; 2023 May; 218(8):352-353. PubMed ID: 37015378
[No Abstract] [Full Text] [Related]
49. Cervical cancer screening: evidence behind the guidelines.
Lees BF; Erickson BK; Huh WK
Am J Obstet Gynecol; 2016 Apr; 214(4):438-443. PubMed ID: 26519782
[TBL] [Abstract][Full Text] [Related]
50. Why is it appropriate to recommend human papillomavirus vaccination as cervical cancer prevention?
Bednarczyk RA; Figueroa-Downing D; Ault K
Am J Obstet Gynecol; 2016 Apr; 214(4):490-493. PubMed ID: 26529369
[No Abstract] [Full Text] [Related]
51. European Code against Cancer 4th Edition: Infections and Cancer.
Villain P; Gonzalez P; Almonte M; Franceschi S; Dillner J; Anttila A; Park JY; De Vuyst H; Herrero R
Cancer Epidemiol; 2015 Dec; 39 Suppl 1():S120-38. PubMed ID: 26589774
[TBL] [Abstract][Full Text] [Related]
52. The cervical cancer prevention programme in Costa Rica.
Rojas IQ
Ecancermedicalscience; 2015; 9():578. PubMed ID: 26557876
[TBL] [Abstract][Full Text] [Related]
53. VALGENT: A protocol for clinical validation of human papillomavirus assays.
Arbyn M; Depuydt C; Benoy I; Bogers J; Cuschieri K; Schmitt M; Pawlita M; Geraets D; Heard I; Gheit T; Tommasino M; Poljak M; Bonde J; Quint W
J Clin Virol; 2016 Mar; 76 Suppl 1():S14-S21. PubMed ID: 26522865
[TBL] [Abstract][Full Text] [Related]
54. Recent changes in trends of mortality from cervical cancer in Southeastern Brazil.
Luizaga CTM; Jardim BC; Wünsch Filho V; Eluf Neto J; Silva GAE
Rev Saude Publica; 2023; 57():25. PubMed ID: 37075421
[TBL] [Abstract][Full Text] [Related]
55. The Relationship between the Serum Level of Selenium and Cervical Intraepithelial Neoplasia: A Comparative Study in a Population of Nigerian Women.
Obhielo E; Ezeanochie M; Olokor O O; Okonkwo A; Gharoro E
Asian Pac J Cancer Prev; 2019 May; 20(5):1433-1436. PubMed ID: 31127904
[TBL] [Abstract][Full Text] [Related]
56. Impact of screening on cervical cancer incidence in England: a time trend analysis.
Pesola F; Sasieni P
BMJ Open; 2019 Jan; 9(1):e026292. PubMed ID: 30679300
[TBL] [Abstract][Full Text] [Related]
57. Mass spectrometry and multivariate analysis to classify cervical intraepithelial neoplasia from blood plasma: an untargeted lipidomic study.
Neves ACO; Morais CLM; Mendes TPP; Vaz BG; Lima KMG
Sci Rep; 2018 Mar; 8(1):3954. PubMed ID: 29500376
[TBL] [Abstract][Full Text] [Related]
58. Beral's 1974 paper: A step towards universal prevention of cervical cancer.
Franceschi S; Vaccarella S
Cancer Epidemiol; 2015 Dec; 39(6):1152-6. PubMed ID: 26514971
[TBL] [Abstract][Full Text] [Related]
59. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
